000			02914nam a22002657a 4500
001			R000714
003			PILC
005			20240718140127.0
008			240718b |||||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _drda
041			_aeng
050			_aOB 2023 0002
245			_aA Comparative study on the effects of carbonyl iron and ferrous sulfate in the prevention of iron deficiency anemia among high-risk pregnant women seen at the out-patient department of a tertiary medical center in 2019 to 2020 / _b[principal investigator]: Lim, Ivy Grace C. [co-author]: Reyes, Lylah D.
260			_aFairview, Quezon City: _bDepartment of Obstetrics & Gynecology, FEU-NRMF, _c2023
300			_c(in folder) _ewith flash drive (soft copy)
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes bibliographical references
520			_aABSTRACT: Background: Iron Deficiency Anemia (IDA), one of global health concerns among pregnant women, contributes to maternal and fetal morbidity and mortality rates. Ferrous Sulfate, a widely prescribed oral iron supplement for prevention and treatment of Iron Deficiency Anemia, has gastrointestinal side effects that affect patient-compliance. Carbonyl Iron has been reported to have less adverse effects but there are limited studies comparing its effects and adverse outcomes with Ferrous Sulfate. Objective: Compare the effect of Carbonyl Iron and Ferrous Sulfate in the prevention of Iron Deficiency Anemia among high-risk pregnant women seen at the Out Patient Department of a tertiary medical center. Methods: This is a retrospective cohort study that reviewed medical records of 415 eligible pregnant women aged 18 to 40 years old seen at the outpatient department of a tertiary medical center from 2019 to 2020 after purposive sampling. Gathered data were encoded using Microsoft Excel and analyzed using intercooled strata version 9.1. Results: Of the 415 eligible medical records reviewed, 50.84% (211) took Ferrous Sulfate and 49.16% (204) were given Carbonyl Iron. There was no significant difference in preventing Iron Deficiency Anemia (p = 0.894) between the two oral iron supplement. Adverse effects such as Nausea (p= 0.962), vomiting (p = 0.894, diarrhea (p= 0.490), constipation (p = 0.326) and gastrointestinal upset (p=0.688) were also comparable. Conclusion: Ferrous sulfate and Carbonyl iron are both comparable in preventing iron deficiency anemia with similar adverse effect profile. Carbonyl iron may be used alternatively among high risk pregnant women within similar or lower price range. Keywords: Ferrous Sulfate, Carbonyl Iron, Iron Deficiency Anemia, Prevention, Adverse Effects
521			_aRESDOG
700			_a Lim, Ivy Grace C. _eprincipal investigator
700			_aReyes, Lylah D. _eco-author
942			_2lcc _cRU
999			_c12758 _d12758